Literature DB >> 8741142

Diagnostic value of in situ muscle fiber conduction velocity measurements in myopathies.

M Naumann1, K Reiners.   

Abstract

In situ studies on muscle fiber conduction velocity (MFCV) were performed in 54 patients with histologically and biochemically defined myopathies. MFCV was measured over a 10 cm segment of the rectus femoris muscle by intramuscular stimulation and recording. Muscle disorders included muscular dystrophies, myotonic dystrophy, inflammatory myopathies, metabolic myopathies, endocrine myopathies, and congenital myopathies with structural abnormalities. Ten healthy volunteers served as controls. MFCV was significantly reduced in all patients except those with a defect in glycolysis and those that had recovered from acute myositis. MFCV did not vary with either sex. age or the duration of the disease. This shows that MFCV slowing is an unspecific finding in most myopathies. However, in some patients with normal needle electromyography, MFCV provided additional information in diagnosing muscle disease.

Entities:  

Mesh:

Year:  1996        PMID: 8741142     DOI: 10.1111/j.1600-0404.1996.tb00198.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  3 in total

1.  Analysis of muscle fiber conduction velocity during finger flexion and extension after stroke.

Authors:  Megan O Conrad; Dan Qiu; Gilles Hoffmann; Ping Zhou; Derek G Kamper
Journal:  Top Stroke Rehabil       Date:  2017-01-05       Impact factor: 2.119

2.  Simultaneous estimation of muscle fibre conduction velocity and muscle fibre orientation using 2D multichannel surface electromyogram.

Authors:  C Grönlund; N Ostlund; K Roeleveld; J S Karlsson
Journal:  Med Biol Eng Comput       Date:  2005-01       Impact factor: 2.602

3.  Increased resistance towards fatigability in patients with facioscapulohumeral muscular dystrophy.

Authors:  Matteo Beretta-Piccoli; Luca Calanni; Massimo Negro; Giulia Ricci; Cinzia Bettio; Marco Barbero; Angela Berardinelli; Gabriele Siciliano; Rossella Tupler; Emiliano Soldini; Corrado Cescon; Giuseppe D'Antona
Journal:  Eur J Appl Physiol       Date:  2021-03-01       Impact factor: 3.078

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.